Cargando…
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
The high case-fatality rate of confirmed MERS-CoV infections underlines the urgent need for an effective treatment to reduce the disease severity and mortality. REGN3051 and REGN3048 are two fully human neutralizing monoclonal antibodies (mAb) against MERS-CoV that reduced virus replication in mice...
Autores principales: | de Wit, Emmie, Feldmann, Friederike, Okumura, Atsushi, Horne, Eva, Haddock, Elaine, Saturday, Greg, Scott, Dana, Erlandson, Karl J., Stahl, Neil, Lipsich, Leah, Kyratsous, Christos A., Feldmann, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113689/ https://www.ncbi.nlm.nih.gov/pubmed/29885377 http://dx.doi.org/10.1016/j.antiviral.2018.06.006 |
Ejemplares similares
-
Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset
por: de Wit, Emmie, et al.
Publicado: (2019) -
Domestic Pig Unlikely Reservoir for MERS-CoV
por: de Wit, Emmie, et al.
Publicado: (2017) -
Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
por: Falzarano, Darryl, et al.
Publicado: (2014) -
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
por: de Wit, Emmie, et al.
Publicado: (2020) -
Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
por: Prescott, Joseph, et al.
Publicado: (2018)